'What does the future hold for cancer?' - a summary of our 2019 patient and public engagement events

Date:
20 December 2019

In 2019 we held six events in our highly successful patient and public engagement series ‘What does the future hold for cancer?', showcasing the progress being made in clinical research at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London (ICR).

           






Figure 1. Feedback from the 2019 series of patient and public events

The future of clinical care through research

The events were attended by a total of 710 people including patients, their relatives, carers and friends (Fig. two), and provided a platform to discuss the latest in clinical research, the impact it is having on treatment and care and hopes for the future. 

 “Gave me much needed background information and food for thought on any treatments I might need”

 

Figure two: The breakdown of attendees across the six BRC patient and public engagement events held in 2019

Research at the BRC

Our engagement events are representing clinical research from across the BRC's six research themes

“It is important for patients and families to be provided with facts and the opportunity to learn more about cancer research”

To find out more about the research discussed at each event, you can read the summary articles below.

Connecting people

The events also enabled patients their relatives, carers and friends to meet and connect with others. This provided a particularly valuable opportunity for patients with rare cancers, many of whom had never met anyone with the same condition, to build a network. 

 “The event really helped me to feel I am not alone in this”.

Upcoming events

The BRC will continue to hold patient and public engagement events in 2020.

Upcoming events will be advertised on the BRC website, via twitter and through the relevant clinical teams and outreach groups. 

Our patient and public engagement events

We regularly hold events to share the  clinical research being carried out at The Royal Marsden and the ICR and the benefits of this research for treatment and care